COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies (2022)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1002/mus.27681
- Subjects: COVID-19; DERMATOPATIAS; MIOSITE; REUMATOLOGIA; VACINAÇÃO; DOENÇAS AUTOIMUNES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Muscle & nerve
- ISSN: 0148-639X
- Volume/Número/Paginação/Ano: v. 66, n. 4, p. 426-437, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GIL-VILA, Albert et al. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, v. 66, n. 4, p. 426-437, 2022Tradução . . Disponível em: https://doi.org/10.1002/mus.27681. Acesso em: 10 fev. 2026. -
APA
Gil-Vila, A., Ravichandran, N., Selva-O'callaghan, A., Sen, P., Nune, A., Gaur, P. S., et al. (2022). COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, 66( 4), 426-437. doi:10.1002/mus.27681 -
NLM
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/mus.27681 -
Vancouver
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1002/mus.27681 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
Informações sobre o DOI: 10.1002/mus.27681 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
